Literature DB >> 18801408

Effects of dihydrotestosterone on differentiation and proliferation of human mesenchymal stem cells and preadipocytes.

Vandana Gupta1, Shalender Bhasin, Wen Guo, Rajan Singh, Rika Miki, Pratibha Chauhan, Karen Choong, Tamara Tchkonia, Nathan K Lebrasseur, John N Flanagan, James A Hamilton, Jason C Viereck, Navjot S Narula, James L Kirkland, Ravi Jasuja.   

Abstract

UNLABELLED: The mechanisms by which androgens regulate fat mass are poorly understood. Although testosterone has been reported to increase lipolysis and inhibit lipid uptake, androgen effects on proliferation and differentiation of human mesenchymal stem cells (hMSCs) and preadipocytes have not been studied. Here, we investigated whether dihydrotestosterone (DHT) regulates proliferation, differentiation, or functional maturation of hMSCs and human preadipocytes from different fat depots. DHT (0-30 nM) dose-dependently inhibited lipid accumulation in adipocytes differentiated from hMSCs and downregulated expression of aP2, PPARgamma, leptin, and C/EBPalpha. Bicalutamide attenuated DHT's inhibitory effects on adipogenic differentiation of hMSCs. Adipocytes differentiated in presence of DHT accumulated smaller oil droplets suggesting reduced extent of maturation. DHT decreased the incorporation of labeled fatty acid into triglyceride, and downregulated acetyl CoA carboxylase and DGAT2 expression in adipocytes derived from hMSCs. DHT also inhibited lipid accumulation and downregulated aP2 and C/EBPalpha in human subcutaneous, mesenteric and omental preadipocytes. DHT stimulated forskolin-stimulated lipolysis in subcutaneous and mesenteric preadipocytes and inhibited incorporation of fatty acid into triglyceride in adipocytes differentiated from preadipocytes from all fat depots.
CONCLUSIONS: DHT inhibits adipogenic differentiation of hMSCs and human preadipocytes through an AR-mediated pathway, but it does not affect the proliferation of either hMSCs or preadipocytes. Androgen effects on fat mass represent the combined effect of decreased differentiation of fat cell precursors, increased lipolysis, and reduced lipid accumulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18801408      PMCID: PMC2873614          DOI: 10.1016/j.mce.2008.08.019

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  51 in total

Review 1.  Modulation by sex hormones of the membranous transducing system regulating fatty acid mobilization in adipose tissue.

Authors:  Y Giudicelli; M N Dieudonne; D Lacasa; Y N Pasquier; R Pecquery
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1993-01       Impact factor: 4.006

2.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

3.  Varying capacities for replication of rat adipocyte precursor clones and adipose tissue growth.

Authors:  H Wang; J L Kirkland; C H Hollenberg
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

4.  The effects of testosterone treatment on body composition and metabolism in middle-aged obese men.

Authors:  P Mårin; S Holmäng; L Jönsson; L Sjöström; H Kvist; G Holm; G Lindstedt; P Björntorp
Journal:  Int J Obes Relat Metab Disord       Date:  1992-12

5.  Cellularity in different regions of adipose tissue in young men and women.

Authors:  L Sjöström; U Smith; M Krotkiewski; P Björntorp
Journal:  Metabolism       Date:  1972-12       Impact factor: 8.694

6.  Adipose tissue cellularity in man: the relationship between fat cell size and number, the mass and distribution of body fat and the history of weight gain and loss.

Authors:  M I Gurr; R T Jung; M P Robinson; W P James
Journal:  Int J Obes       Date:  1982

7.  Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues.

Authors:  P Mårin; M Krotkiewski; P Björntorp
Journal:  Eur J Med       Date:  1992-10

8.  Growth of adipose tissue in infants, children and adolescents: variations in growth disorders.

Authors:  F Ginsberg-Fellner
Journal:  Int J Obes       Date:  1981

Review 9.  Genetic aspects of susceptibility to obesity and related dyslipidemias.

Authors:  J P Després; S Moorjani; P J Lupien; A Tremblay; A Nadeau; C Bouchard
Journal:  Mol Cell Biochem       Date:  1992-08-18       Impact factor: 3.396

10.  Gene expression analyses in cynomolgus monkeys provides mechanistic insight into high-density lipoprotein-cholesterol reduction by androgens in primates.

Authors:  Pascale Nantermet; Shun-ichi Harada; Yuan Liu; Spring Cheng; Colena Johnson; Yuanjiang Yu; Donald Kimme; Daniel Holder; Paul Hodor; Robert Phillips; William J Ray
Journal:  Endocrinology       Date:  2008-01-10       Impact factor: 4.736

View more
  48 in total

Review 1.  Nuclear receptor regulation of stemness and stem cell differentiation.

Authors:  Yangsik Jeong; David J Mangelsdorf
Journal:  Exp Mol Med       Date:  2009-08-31       Impact factor: 8.718

2.  Identification of a clinically relevant androgen-dependent gene signature in prostate cancer.

Authors:  Hannelore V Heemers; Lucy J Schmidt; Zhifu Sun; Kevin M Regan; S Keith Anderson; Kelly Duncan; Dan Wang; Song Liu; Karla V Ballman; Donald J Tindall
Journal:  Cancer Res       Date:  2011-02-15       Impact factor: 12.701

3.  Novel strategies for improving physical function.

Authors:  Shalender Bhasin; Ravi Jasuja; Powen Tu; Thomas W Storer; Wen Guo
Journal:  Horm Res Paediatr       Date:  2011-07-21       Impact factor: 2.852

Review 4.  Hypogonadism and metabolic syndrome.

Authors:  G Corona; G Rastrelli; A Morelli; L Vignozzi; E Mannucci; M Maggi
Journal:  J Endocrinol Invest       Date:  2011-06-27       Impact factor: 4.256

Review 5.  Prohibitin: A hypothetical target for sex-based new therapeutics for metabolic and immune diseases.

Authors:  Suresh Mishra; Bl Grégoire Nyomba
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-04

Review 6.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

Review 7.  Selective androgen receptor modulators as function promoting therapies.

Authors:  Shalender Bhasin; Ravi Jasuja
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2009-05       Impact factor: 4.294

8.  Rapid selection of mesenchymal stem and progenitor cells in primary prostate stromal cultures.

Authors:  W Nathaniel Brennen; L Nelleke Kisteman; John T Isaacs
Journal:  Prostate       Date:  2016-01-06       Impact factor: 4.104

Review 9.  The complex and multifactorial relationship between testosterone deficiency (TD), obesity and vascular disease.

Authors:  Abdulmaged M Traish; Michael Zitzmann
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

10.  Androgens inhibit adipogenesis during human adipose stem cell commitment to preadipocyte formation.

Authors:  Gregorio Chazenbalk; Prapti Singh; Dana Irge; Amy Shah; David H Abbott; Daniel A Dumesic
Journal:  Steroids       Date:  2013-05-23       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.